News

Ophthalmology Times48m
A look at the vorolanib intravitreal insert compared with aflibercept for DME
EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...
Ophthalmology Times53m
Boehringer Ingelheim launches phase 2 study of oral therapy for diabetic macular edema
Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...